Position in AGIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Derivatives in AGIO
reported options exposure · as of Mar 31, 2026CallValue
$3,044,700
CallShares
90,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caligan Partners LP holds $1,087,463,397 across 22 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,461,924 | $162,785,237 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
1,652,808 | $160,735,578 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
2,060,719 | $119,748,381 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
1,393,027 | $81,004,520 | |
| 5 | MLYS |
Mineralys Therapeutics, Inc.
|
2,772,654 | $75,111,196 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,553,262 | $66,619,407 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
2,408,798 | $50,392,054 | |
| 8 | TYRA |
Tyra Biosciences, Inc.
|
1,276,968 | $48,907,874 |
All Filings in AGIO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,044,700 | 90,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $2,449,800 | 90,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $39,136,500 | 975,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $45,406,568 | 1,131,205 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,630,041 | 1,071,258 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,547,504 | 701,280 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,579,560 | 626,280 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $25,756,826 | 579,717 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,194,338 | 514,711 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,172,949 | 484,711 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,839,620 | 441,833 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $119,616 | 4,833 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $136,870 | 4,833 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $99,529 | 4,333 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $121,670 | 4,333 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||